News & Events:RGEN

Repligen Corporation (RGEN) today announced the appointment to its Board of Directors of Konstantin Konstantinov, Ph.D., a life sciences and bioprocessing industry expert. Dr. Konstantinov has been directly involved in the development and commercialization of multiple biotherapeutic modalities, including monoclonal antibodies, blood factors, gene therapy vectors and exosomes.

Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at three upcoming investor conferences.

According to Benzinga Pro, during Q1, Repligen earned $46.96 million, a 61.33% increase from the preceding quarter. Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.

Check out this: Adobe And 3 Other Stocks Insiders Are Selling Don't forget to check out our premarket coverage here .

62 Biggest Movers From Yesterday

 Gainers Vivakor, Inc. gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of up to $250 million.  Losers Molecular Partners AG shares dipped 37.6% to $8.60. The company's collaborating partner Amgen for MP0310 will return the global rights of MP0310 to Molecular Partners following a strategic pipeline review.  

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.91% to 33,543.56 while the NASDAQ rose 1.55% to 12,683.73. The S&P also rose, gaining, 1.19% to 4,224.93.

Here's a roundup of top developments in the biotech space over the last 24 hours. Pfizer Inc  and BioNTech SE  have submitted an FDA Emergency Use Authorization application for a 10-µg booster dose of COVID-19 Vaccine for children 5 through 11 years of age.

  Repligen reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Repligen beat estimated earnings by 27.78%, reporting an EPS of $0.92 versus an estimate of $0.72. Revenue was up $63.56 million from the same period last year.

Repligen Corp (RGEN): * REPLIGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND UPDATES FULL YEAR 2022 FINANCIAL GUIDANCE. * Q1 GAAP EARNINGS PER SHARE $0.81. * Q1 REVENUE ROSE 45 PERCENT TO $206.4 MILLION. * QTRLY ADJUSTED FULLY DILUTED EPS INCREASED TO $0.92. * TOTAL REVENUE IS EXPECTED TO BE IN RANGE OF $770-$800 MILLION FOR FY 2022.

—Record revenue of $206.4 million for the quarter, and year-over-year growth of 45% as reported and 48% at constant currency —Organic revenue growth of 44% for the quarter and base business growth of 37% —Growth driven by combination of base business strength, COVID-related demand, and acquisition revenue WALTHAM, Mass., April 27, 2022 -- Repligen Corporation (RGEN), a life sciences company focused on...

  ** Deutsche Bank is projected to report earnings for its first quarter. ** Oshkosh is estimated to report quarterly earnings at $0.16 per share on revenue of $1.88 billion. ** Solid Biosciences is projected to report quarterly loss at $0.18 per share on revenue of $2.68 million. ** LG Display Co is likely to report quarterly earnings at $0.02 per share on revenue of $5.58 billion.

  During Tuesday, 581 stocks hit new 52-week lows. Meta Platforms was the biggest company on a market cap basis to set a new 52-week low. The smallest company by market cap to set a new 52-week low was AnPac Bio-Medical Science. During Tuesday, the following stocks broke to new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  On Monday, 721 companies achieved new lows for the year. During Monday, the following stocks set new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  On Friday, 431 companies hit new 52-week lows. Here are all the stocks that set new 52-week lows on Friday: Be sure to stay with Benzinga for further updates and market-moving news.

Repligen will host a conference call at 08:30 AM ET on April 27, 2022, to discuss Q1 2022 earnings results. Follow this link to access the live webcast. To listen to the call, dial 274-3999 or 317-5607. Earnings conference calls allow companies to talk about their recent earnings reports publicly, so that anyone who is interested can get more information on what happened and why it happened.

  On Tuesday, 242 companies hit new 52-week lows. The stocks that set new 52-week lows on Tuesday: Be sure to stay with Benzinga for further updates and market-moving news.

  On Monday, 466 companies hit new 52-week lows. Stocks that set new 52-week lows on Monday are as follows:   Be sure to monitor Benzinga for the news traders need!

Repligen Corporation (RGEN) today announced that the Company will report its first quarter 2022 financial results on Wednesday, April 27, 2022. The conference call will be accessible by dialing toll-free 274-3999 for domestic callers and 317-5607 for international callers.

Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the KeyBanc Life Science and MedTech Investor Forum being held March 22-23, 2022.